Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Mintz Levin Represents Cyclacel Pharmaceuticals Inc. in Sale of Patents to Celgene Corporation For $5.5 Million and Dismissal of



  Mintz Levin Represents Cyclacel Pharmaceuticals Inc. in Sale of Patents to
  Celgene Corporation For $5.5 Million and Dismissal of All Claims Against
  Celgene in Patent Litigation

Business Wire

NEW YORK -- April 5, 2013

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Cyclacel
Pharmaceuticals Inc. in a patent infringement action in which Cyclacel accused
Celgene Corporation of infringing four patents related to the use of
romidepsin to treat disease. (D.Del. 1:10‐cv‐00348‐GMS).

The two companies have filed a joint stipulation and the Court has entered an
order dismissing the pending litigation. The parties entered into a definitive
agreement with Cyclacel selling the four Cyclacel‐owned patents to Celgene. In
connection with the agreement Celgene has made to Cyclacel a one‐time payment
of $5.5 million.

Cyclacel is a biopharmaceutical company developing oral therapies that target
the various phases of cell cycle control for the treatment of cancer and other
serious diseases.

Representing Cyclacel in the patent litigation agreement were John Bauer, Ivor
Elrifi, Marv Gittes and Timur Slomin, Members in the Intellectual Property
Practice. Avisheh Avini, an associate in the firm’s Corporate & Securities
Practice, also assisted in the agreement.

For more information about Mintz Levin, please visit www.mintz.com.

Contact:

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Gina Addis, 617-348-4413
GADDIS@MINTZ.COM
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement